Inicio Blog Página 62

Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis

0

In this phase 2 trial, tulisokibart (a tumor necrosis factor–like cytokine 1A monoclonal antibody) was more effective than placebo in inducing clinical remission in patients with ulcerative colitis.

​   The New England Journal of Medicine: Search Results in Allergy/Immunology

Prostate Biopsy in Men with an Elevated PSA Level — Reducing Overdiagnosis

0

Research into magnetic resonance imaging (MRI) for prostate cancer screening and diagnosis has been ongoing for more than a decade. Initially, MRI was thought to be important for achieving two goals. Among patients with low-grade (International Society of Urological Pathology [ISUP] grade 1, also called Gleason grade group 1) disease…

​   The New England Journal of Medicine: Search Results in Hematology/Oncology

Pilar Manchón, en el corazón de la IA en español

0

Lingüista, ingeniera, emprendedora y científica: la ejecutiva de Google impulsa el crecimiento de la IA en el mundo.

​Lingüista, ingeniera, emprendedora y científica: la ejecutiva de Google impulsa el crecimiento de la IA en el mundo.   Noticias sobre negocios

Renuncia Mira Murati, jefa de tecnología de OpenAI

0

En una carta al equipo de OpenAI publicada en X, Murati escribió que «este es el momento adecuado» para dimitir.

​En una carta al equipo de OpenAI publicada en X, Murati escribió que «este es el momento adecuado» para dimitir.   Noticias sobre negocios

Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus Infection

0

In a phase 3 trial involving infants in China, ziresovir, an orally administered RSV F protein inhibitor, led to an improvement in the Wang bronchiolitis score at day 3 and a decline in the RSV viral load by day 5.

​   The New England Journal of Medicine: Search Results in Pediatrics

Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia B

0

In participants with hemophilia B, fidanacogene elaparvovec was superior to factor IX prophylaxis, with a lower bleeding rate and stable factor IX expression.

​   The New England Journal of Medicine: Search Results in Pediatrics

Creeping toward Effective Antiviral Agents for RSV Infection

0

Infection with respiratory syncytial virus (RSV), the cause of annual winter epidemics of respiratory illness in all age groups, is best recognized for being the leading diagnosis in very young infants who are hospitalized.1 The recent licensure of an RSV prefusion fusion protein (preF) vaccine to be administered…

​   The New England Journal of Medicine: Search Results in Pediatrics

Creeping toward Effective Antiviral Agents for RSV Infection

0

Infection with respiratory syncytial virus (RSV), the cause of annual winter epidemics of respiratory illness in all age groups, is best recognized for being the leading diagnosis in very young infants who are hospitalized.1 The recent licensure of an RSV prefusion fusion protein (preF) vaccine to be administered…

​   The New England Journal of Medicine: Search Results in Infectious Disease

Ziresovir in Hospitalized Infants with Respiratory Syncytial Virus Infection

0

In a phase 3 trial involving infants in China, ziresovir, an orally administered RSV F protein inhibitor, led to an improvement in the Wang bronchiolitis score at day 3 and a decline in the RSV viral load by day 5.

​   The New England Journal of Medicine: Search Results in Infectious Disease

Neuroleptic Malignant Syndrome

0

Neuroleptic malignant syndrome, characterized by fever, muscular rigidity, and dysautonomia, occurs with exposure to dopamine-blocking agents. Management, especially in critical care contexts, is described.

​   The New England Journal of Medicine: Search Results in Pulmonary/Critical Care